why choose us

First received: August 20, 2024

Clinical Trial: "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Major Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder

Brief Summary: The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.

Read more